Table 2.
Population | Sera analyzed | Pestivirus | Herpesvirus | BTV | MAP | Brucella | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sera* | Prevalence (%) | Sera* | Prevalence (%) | Sera* | Prevalence (%) | Sera* | Prevalence (%) | Sera* | Prevalence (%) | ||
95% CI | 95% CI | 95% CI | 95% CI | 95% CI | |||||||
A | 61 | 0/61 | 0 | 0/61 | 0 | 0/21 | 0 | 10/61 | 16.4 | 0/42 | 0 |
(0-4.87) | (0-4.87) | (0-15.8) | (8.74-27.74) | (0-8.92) | |||||||
B | 79 | 1/79 | 1.3 | 0/79 | 0 | 0/27 | 0 | 8/79 | 10.1 | 0/37 | 0 |
(0.07-6.75) | (0-4.75) | (0-12.38) | (4.76-18.84) | (0-9.05) | |||||||
C | 120 | 2/120 | 1.7 | 0/120 | 0 | 0/16 | 0 | 6/120 | 5 | 0/30 | 0 |
(0.03-6.06) | (0-3.13) | (0-20.83) | (2.2-10.69) | (0-11.15) | |||||||
D | 113 | 2/113 | 1.8 | 0/113 | 0 | 0/42 | 0 | 11/113 | 9.7 | 0/26 | 0 |
(0.03-6.44) | (0-3.32) | (0-8.92) | (5.16-16.7) | (0-12.85) | |||||||
E | 15 | 0/15 | 0 | 1/15 | 6.7 | 0/14 | 0 | 2/15 | 13.3 | 0/10 | 0 |
(0-22.22) | (0.35-30.2) | (0-23.81) | (2.43-39.67) | (0-29.08) | |||||||
F | 74 | 3/74 | 4.1 | 0/71 | 0 | 0/41 | 0 | 7/74 | 9.46 | 0/19 | 0 |
(1.12-11.29) | (0-4.79) | (0-8.17) | (4.53-18.72) | (0-17.65) | |||||||
G | 8 | 0/8 | 0 | 0/8 | 0 | 0/1 | 0 | 0/8 | 0 | 0/7 | 0 |
(0-37.71) | (0-36.46) | (0-94.99) | (0-36.46) | (0-37.71) | |||||||
H | 49 | 0/49 | 0 | 0/49 | 0 | 0/10 | 0 | 4/49 | 8.2 | 0/30 | 0 |
(0-7.65) | (0-7.65) | (0-29.08) | (2.84-19.18) | (0-11.15) | |||||||
Total | 519 | 8/519 | 1.5 | 1/516 | 0.2 | 0/172 | 0 | 48/519 | 9.2 | 0/201 | 0 |
(0.05-3.04) | (0-1.1) | (0-2.18) | (7.01-12.11) | (0-1.87) |
*positive sera/tested sera